ON DEMAND CANAKINUMAB THERAPY FOR COLCHICINE RESISTANT FAMILIAL MEDITERRANEAN FEVER (FMF) PAEDIATRIC PATIENTS - A MULTICENTER STUDY

被引：0
|
作者：
Shehadeh, K. [1 ]
Levinsky, Y. [1 ,2 ]
Tal, R. [1 ,2 ]
Kagan, S. [3 ]
Zoabi, T. [3 ]
Harel, L. [1 ,2 ]
Amarilyo, G. [1 ,2 ]
机构：
[1] Tel Aviv Univ, Scakler Sch Med, Tel Aviv, Israel
[2] Schneider Childrens Med Ctr, Pediat Dept B, Petah Tiqwa, Israel
[3] Schneider Childrens Med Ctr, Pediat Dept B, Petah Tiqwa, Israel
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Quality of care;
D O I：
10.1136/annrheumdis-2023-eular.6147
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0758
引用
收藏
页码：670 / 671
页数：2
相关论文
共 50 条
  • [11] Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment
    Karabulut, Yusuf
    Gezer, Halise Hande
    Duruoez, Mehmet Tuncay
    [J]. RHEUMATOLOGY INTERNATIONAL, 2022, 42 (01) : 81 - 86
  • [12] Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever
    Sener, Seher
    Cam, Veysel
    Batu, Ezgi Deniz
    Kasap Cuceoglu, Muserref
    Balik, Zeynep
    Aliyev, Emil
    Bayindir, Yagmur
    Basaran, Ozge
    Bilginer, Yelda
    Ozen, Seza
    [J]. RHEUMATOLOGY, 2023, 62 (11) : 3700 - 3705
  • [13] Efficacy and Safety of Canakinumab in Adults with Colchicine Resistant Familial Mediterranean Fever
    Gul, A.
    Ozdogan, H.
    Erer, B.
    Ugurlu, S.
    Davis, Nicole
    Sevgi, S.
    Kasapcopur, O.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S322 - S322
  • [14] CANAKINUMAB THERAPY IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
    Ugurlu, S.
    Seyahi, E.
    Hatemi, G.
    Hacioglu, A.
    Akkoc, N. F.
    Ozdogan, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 320 - 321
  • [15] Canakinumab therapy in patients with Familial Mediterranean Fever
    S Ugurlu
    E Seyahi
    G Hatemi
    A Hacioglu
    H Ozcan
    FN Akkoc
    H Ozdogan
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
  • [16] Canakinumab Therapy in Patients with Familial Mediterranean Fever
    Ugurlu, Serdal
    Seyahi, Emire
    Hatemi, Gulen
    Hacioglu, Aysa
    Ozcan, Humeyra
    Akkoc, Fatma Nihan
    Ozdogan, Huri
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [17] INFLAMMATORY REACTION IN FAMILIAL MEDITERRANEAN FEVER (FMF) BEFORE AND WITH COLCHICINE THERAPY
    OLLIERHARTMANN, MP
    GODEAU, P
    HARTMANN, L
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1984, 38 (9-10) : 448 - 455
  • [18] Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
    Ali Şahin
    Mehmet Emin Derin
    Fatih Albayrak
    Burak Karakaş
    Yalçın Karagöz
    [J]. Advances in Rheumatology, 60
  • [19] EXPERIENCE OF ANAKINRA AND CANAKINUMAB IN PATIENTS WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER AND COMPLICATED WITH AMYLOIDOSIS
    Sahin, Ali
    Derin, Mehmet Emin
    Albayrak, Fatih
    Karakas, Burak
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 582 - 582
  • [20] Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
    Sahin, Ali
    Derin, Mehmet Emin
    Albayrak, Fatih
    Karakas, Burak
    Karagoz, Yalcin
    [J]. ADVANCES IN RHEUMATOLOGY, 2020, 60 (01)
12345